AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 139 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,269 | -16.7% | 16,903 | -33.2% | 0.00% | – |
| Q2 2023 | $23,136 | -70.1% | 25,285 | -81.7% | 0.00% | -100.0% |
| Q1 2023 | $77,356 | +60.0% | 138,037 | +64.8% | 0.00% | +100.0% |
| Q4 2022 | $48,334 | +504.2% | 83,768 | +220.5% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 26,134 | -26.6% | 0.00% | – |
| Q2 2022 | $13,000 | -43.5% | 35,599 | +10.7% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | -68.9% | 32,169 | -2.3% | 0.00% | -66.7% |
| Q4 2021 | $74,000 | +19.4% | 32,911 | +54.1% | 0.00% | +50.0% |
| Q3 2021 | $62,000 | +29.2% | 21,361 | +52.1% | 0.00% | -33.3% |
| Q1 2021 | $48,000 | -75.3% | 14,046 | -54.2% | 0.00% | +200.0% |
| Q4 2019 | $194,000 | +240.4% | 30,694 | +198.4% | 0.00% | 0.0% |
| Q4 2018 | $57,000 | – | 10,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |